Can I Take Laxatives with Mounjaro?

Why does Mounjaro cause constipation in the first place?

Tirzepatide activates both GIP and GLP-1 receptors, two gut-hormone pathways that regulate appetite and blood-sugar response. One consequence of that dual action is a marked slowing of gastric emptying: food leaves the stomach more gradually, which is part of why appetite falls so effectively. Further down the tract, bowel transit also slows for many people. The result is that constipation is among the most frequently reported side effects during treatment, especially in the days following a dose increase.

The NHS tirzepatide page lists constipation alongside nausea and diarrhoea as common gastrointestinal effects. It tends to be most noticeable in the adjustment phase rather than a permanent fixture, and for many patients adequate fluid intake and increased fibre are enough to resolve it. Knowing that your gut is already moving more slowly is important context for choosing what to take if dietary measures are not sufficient.

Which laxatives are generally appropriate alongside Mounjaro?

Most pharmacists would point you towards an osmotic laxative first. Products containing macrogol (polyethylene glycol) work by drawing water into the bowel to soften and bulk the stool, rather than by pushing the intestine to contract more forcefully. Because Mounjaro has already altered gut muscle tone and transit speed, adding a stimulant laxative on top can occasionally lead to unpredictable cramping or diarrhoea, which is uncomfortable and can contribute to dehydration — something to take seriously when you may already be eating and drinking less than usual.

Bulk-forming laxatives such as ispaghula husk are also a reasonable option, provided you are drinking enough water; without adequate fluid they can worsen blockage rather than help. If you are weighing up the different approaches and what fits your situation, our frequently asked questions section covers a range of treatment queries that come up regularly.

Glycerol suppositories and lactulose sit somewhere in between and are generally considered lower-risk additions, though lactulose can cause bloating, which may compound existing Mounjaro-related GI discomfort. The practical takeaway: osmotic first, stimulant with caution, and keep your prescriber in the loop if you find yourself reaching for laxatives more than occasionally.

Are there any laxatives that interact directly with tirzepatide?

There is no widely documented pharmacokinetic interaction between tirzepatide and standard over-the-counter laxatives in the way that, say, some antibiotics interact with oral contraceptives. The concern is functional rather than chemical: Mounjaro shifts gut motility, and laxatives shift it further. The two effects together can tip the balance from constipation into loose stools rapidly, and repeated bouts of diarrhoea raise the risk of dehydration. Dehydration on a GLP-1 medicine carries its own risks, including strain on the kidneys, which is a reason to flag things to your prescriber if symptoms are cycling between the two extremes.

People with pre-existing bowel conditions face a more nuanced picture. If you are managing ulcerative colitis or another inflammatory bowel condition, the interaction between Mounjaro's gut effects and your baseline symptoms needs individual clinical assessment. Similarly, anyone with chronic kidney disease should read about taking Mounjaro with CKD before making decisions about dehydration risk.

When should constipation prompt a call to your prescriber rather than a trip to the pharmacy?

Picking up a box of macrogol from the chemist on a Tuesday morning is a perfectly reasonable first step for mild, new-onset constipation. What needs more than a pharmacy conversation is constipation that lasts more than a week without improvement, is accompanied by significant abdominal pain, or is joined by other symptoms you cannot explain. Severe stomach pain that radiates to the back requires urgent medical attention: the MHRA's Drug Safety Update on GLP-1 medicines highlights acute pancreatitis as an infrequent but serious risk, and one of its warning signs is exactly that kind of persistent, spreading abdominal pain.

If your bowel symptoms are making it hard to stay hydrated or are affecting your ability to eat, that is also a prescriber conversation, not a larger laxative dose. Mounjaro's dose titration schedule exists partly to manage GI tolerability, and a prescriber can adjust the pace of that schedule if the side-effect burden is high. You can explore general eligibility and suitability criteria on our BMI and Mounjaro eligibility page, or learn more about starting treatment on our can I take Mounjaro overview, which also links to our guidance on taking Mounjaro with epilepsy for anyone managing that condition alongside their weight treatment. If you are already on treatment and managing symptoms, additional detail on laxatives during Mounjaro treatment may also be useful. For personalised guidance on your specific situation, speak to our prescribers through a free consultation.